CStone Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

SEHK:2616 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
11 Oct 23BuyHK$94,500Jianxin YangIndividual50,000HK$1.89
05 Oct 23BuyHK$249,332Jianxin YangIndividual148,500HK$1.68
04 Oct 23BuyHK$384,522Jianxin YangIndividual231,000HK$1.66
03 Oct 23BuyHK$377,843Jianxin YangIndividual222,000HK$1.70
13 Jul 23SellHK$9,411,498Suzhou Oriza Holdings Co., Ltd.Company3,712,914HK$2.53
03 Jul 23BuyHK$1,120,372Jianxin YangIndividual452,000HK$2.48
20 Jun 23BuyHK$544,299Jianxin YangIndividual210,000HK$2.59
19 Jun 23BuyHK$675,999Jianxin YangIndividual250,000HK$2.70
02 Jun 23BuyHK$443,098Jianxin YangIndividual155,000HK$2.86
01 Jun 23BuyHK$140,000Jianxin YangIndividual50,000HK$2.80
01 Jun 23SellHK$37,678,077Suzhou Oriza Holdings Co., Ltd.Company13,954,828HK$2.70
31 May 23BuyHK$267,763Jianxin YangIndividual96,000HK$2.79
30 May 23BuyHK$281,000Jianxin YangIndividual100,000HK$2.81
29 May 23BuyHK$284,500Jianxin YangIndividual100,000HK$2.85
15 May 23BuyHK$90,846Jianxin YangIndividual30,000HK$3.03
12 May 23BuyHK$459,000Jianxin YangIndividual150,000HK$3.06
11 May 23BuyHK$27,900Jianxin YangIndividual9,000HK$3.10
10 May 23BuyHK$268,497Jianxin YangIndividual90,000HK$2.98
09 May 23BuyHK$456,900Jianxin YangIndividual150,000HK$3.05

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 2616?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders48,332,1483.79%
Public Companies115,928,8039.1%
Institutions147,144,49011.5%
General Public451,182,59135.4%
VC/PE Firms511,495,62240.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 20 shareholders own 64.59% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
23%
6 Dimensions Capital, L.P.
293,381,444HK$264.0m0%11.03%
11.2%
Boyu Capital Group Management Ltd.
142,560,448HK$128.3m0%1.94%
9.1%
Pfizer Inc.
115,928,803HK$104.3m0%no data
5.93%
Suzhou Oriza Holdings Co., Ltd.
75,553,730HK$68.0m0%1.59%
4.66%
GIC Private Limited
59,422,472HK$53.5m0%0.01%
3.8%
Tetrad Ventures Pte. Ltd.
48,392,472HK$43.6m0%100.0%
2.35%
Ningjun Jiang
29,985,397HK$27.0m0%no data
1.39%
The Vanguard Group, Inc.
17,657,500HK$15.9m1.54%no data
1.16%
Bosera Asset Management Co., Ltd.
14,788,000HK$13.3m0%0.01%
0.88%
Jianxin Yang
11,240,756HK$10.1m6.15%no data
0.53%
Xiao Yanni
6,760,000HK$6.1m0%no data
0.25%
GF Fund Management Co., Ltd.
3,170,500HK$2.9m0%no data
0.18%
Franklin Resources, Inc.
2,280,000HK$2.1m0%no data
0.058%
Xin Yuan Asset Management Company
745,000HK$670.5k0%0.05%
0.04%
Morgan Stanley, Investment Banking and Brokerage Investments
506,036HK$455.5k0%no data
0.027%
Hitchner III Walton
345,995HK$311.4k0%no data
0.011%
State Street Global Advisors, Inc.
144,500HK$130.0k-19.1%no data
0.0018%
E*Trade Financial Holdings, LLC, Asset Management Arm
23,010HK$20.8k0%50.14%
0.0009%
BlackRock, Inc.
11,500HK$10.3k-99.9%no data
0.00027%
Dacheng Fund Management Co., Ltd.
3,500HK$3.1k0%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.